1. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies
- Author
-
E Flatter, E Metzger, S Evrard, Aprahamian M, A. Hajri, F Vallat, S Coffy, and J. Marescaux
- Subjects
Lipopolysaccharides ,Male ,Nitroprusside ,Cancer Research ,medicine.medical_specialty ,Nitric Oxide Synthase Type II ,DNA Fragmentation ,Arginine ,Nitric Oxide ,Nitric oxide ,Mice ,chemistry.chemical_compound ,Internal medicine ,Tumor Cells, Cultured ,medicine ,Animals ,Mice, Inbred C3H ,Dose-Response Relationship, Drug ,biology ,Cell growth ,Macrophages ,Carcinoma ,Apoptotic DNA fragmentation ,DNA, Neoplasm ,Macrophage Activation ,Molecular biology ,Rats ,Pancreatic Neoplasms ,Nitric oxide synthase ,Endocrinology ,Oncology ,chemistry ,Rats, Inbred Lew ,Apoptosis ,Cell culture ,biology.protein ,Tumor necrosis factor alpha ,Nitric Oxide Synthase ,Growth inhibition ,Cell Division ,Research Article - Abstract
Nitric oxide (NO), an endogenous free radical, has been implicated in a wide range of biological functions. NO is generated enzymatically from the terminal guanidinonitrogen of L-arginine by nitric oxide synthase (NOS). Despite intensive investigations, the role of NO--either as the primary product of the L-arginine/NOS pathway or provided from the NO donor sodium nitroprusside (SNP)--in carcinogenesis and tumour cell growth remains unclear and controversial. The objective of this study was to examine the growth effects of NO on a ductal pancreatic adenocarcinoma in the rat and on a human pancreatic tumour cell line (HA-hpc2). In vivo, both SNP and endogenous induction of NO by endotoxins [lipopolysaccharide (LPS)] plus L-arginine significantly reduced the tumour growth. To investigate the mechanisms of NO anti-tumour growth action, the effects of either the SNP or L-arginine/NOS pathway were analysed on the HA-hpc2 cell line. Nitrite/nitrate production, NOS activity and iNOS expression [assessed by reverse transcription-polymerase chain reaction (RT-PCR)] were tested and related to growth (assessed by [3H]thymidine incorporation assay) and apoptosis (assessed by internucleosomal DNA cleavage). SNP exerted a dual effect on tumour cells: stimulation of the proliferation up to 1 mM and inhibition at higher concentrations. These effects were related to NO production. Both proliferative and cytostatic responses were inhibited by NO scavenger 2-phenyl-4,4,5,5-tetramethyl-hemidazoline-1-oxyl3-oxide (carboxy-PTIO). The marked apoptotic DNA fragmentation induced by SNP was also abolished by PTIO association. Unlike macrophages, the human pancreatic tumour cells did not seem to express intrinsically the L-arginine/NOS pathway. Macrophages were activated by HA-hpc2 cells as well as by LPS plus cytokines [interleukin (IL)-1beta plus tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma]. In HA-hpc2/macrophage co-cultures, NOS activity and inducible NOS (iNOS) transcription were stimulated, whereas an antiproliferative response was observed. These effects were related to both macrophage amount and NO production. Addition of LPS plus cytokines to co-cultures doubled iNOS activity, nitrite/nitrate production and tumoricidal effect. These data suggest the involvement of NO in pancreatic tumour growth and support the fact that generation of high levels of NO with potential production of endogenous reactive nitrogen intermediates may contribute to induction of apoptosis and tumour growth inhibition. Images Figure 2 Figure 5 Figure 6 Figure 7
- Published
- 1998